双特异性免疫疗法MEDI5752或volrustomig和子宫癌
Chinmoy K Bose1,2, Nirban Basu3
1Netaji Subhas Chandra Bose Cancer Hospital, Kolkata, India.
Journal of gynecologic oncology
|May 24, 2024
概括
MEDI5752是一种新的双特异性免疫疗法,独特地结合了抗PD-1和抗CTLA-4的作用. 它的开发之旅,从发明到第三阶段试验,是详细的,提供了对这个突破性的分子的历史见解.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 药物开发 药物开发
背景情况:
- 梅迪5752是第一类单价双特异性免疫疗法.
- 它独特地结合了抗编程细胞死亡1 (PD-1) 和抗细胞毒性T淋巴细胞相关蛋白4 (CTLA-4) 活性.
- 这种新型分子的历史发展在临床瘤学文献中经常被低估.
研究的目的:
- 为了记录MEDI的发明和发展历史5752.2.
- 提供关于该分子到达III期临床试验的旅程的全面描述.
- 填补关于这种独特免疫疗法的早期阶段的出版文献中的空白.
主要方法:
- 对历史发展数据的审查.
- 关键事件的年代记录.
- 对早期临床试验结果的分析 (第一阶段).
主要成果:
- 梅迪5752代表了双特异性免疫疗法设计的重大进步.
- 早期I阶段的结果虽然有限,但提供了关于其发展轨迹的初步数据.
- 发展叙述强调了在创造双作用免疫疗法方面面临的独特挑战和里程碑.
结论:
- 详细的MEDI5752发展史为未来的免疫疗法研究提供了宝贵的见解.
- 了解新疗法的完整生命周期对于科学进步至关重要.
- 由于MEDI5752的独特双特异性机制,在III期试验中需要进一步调查.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
相关概念视频
01:27Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
01:30Cancer Vaccines
355
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
355
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K